Rheumatology Journal Club Debut: #rheumjc At a Glance

Did you miss the two-session Twitter chat about a lupus nephritis study, the first-ever journal club for rheumatology? No problem! RheumNet has condensed all 500 tweets into 11 well-organized slides. "Excellent summary with loads of great soundbites!" said one rheumatologist.


lupus nephritis

Lupus nephritis (LN) flares can arise for 15 years, a newly published longitudinal study shows. Other research reveals predictors of LN outcomes.

Rheumatology tests top the list of FDA-approved biomarker panels today. But the most prominent of these has fallen from favor, and rheumatology doesn't even rate a mention in the Precision Medicine Initiative.


About half of patients taking hydroxychloroquine, which is used for lupus and rheuamtoid arthritis, aren't tested in time for its blinding effects on the retina, says a review. There are simple ways to use the drug safely.

Antinuclear antibody testing and DEXA both appear on a new Canadian list of rheumatology tests to avoid and on a similar 2013 list from the American College of Rheumatology. There are interesting differences in the other 3 choices.

This lupus patient likes her rheumatologist but sometimes hates seeing him. She gives two reasons for this, and offers suggestions to improve the relationship.

intestinal pseudo-obstruction

A retrospective study in China defines the prevalence and course of disorders of the intestines or ureter secondary to systemic lupus erythematosus.

lupus nephritis

Even if you missed participating in the first-ever rheumatology journal club on Twitter last week at #rheumjc, you can relive the conversation, condensed and edited, in fewer than a dozen slides.


Subscribe to Lupus on [sitename]

By clicking Accept, you agree to become a member of the UBM Medica Community.